| Literature DB >> 34260912 |
Anna-Lisa Lanz1, Giulia Masi1, Nicla Porciello1, André Cohnen1, Deborah Cipria1, Dheeraj Prakaash2, Štefan Bálint3, Roberto Raggiaschi1, Donatella Galgano1, David K Cole4, Marco Lepore5, Omer Dushek6, Michael L Dustin3, Mark S P Sansom7, Antreas C Kalli8, Oreste Acuto9.
Abstract
The mechanism of T cell antigen receptor (TCR-CD3) signaling remains elusive. Here, we identify mutations in the transmembrane region of TCRβ or CD3ζ that augment peptide T cell antigen receptor (pMHC)-induced signaling not explicable by enhanced ligand binding, lateral diffusion, clustering, or co-receptor function. Using a biochemical assay and molecular dynamics simulation, we demonstrate that the gain-of-function mutations loosen the interaction between TCRαβ and CD3ζ. Similar to the activating mutations, pMHC binding reduces TCRαβ cohesion with CD3ζ. This event occurs prior to CD3ζ phosphorylation and at 0°C. Moreover, we demonstrate that soluble monovalent pMHC alone induces signaling and reduces TCRαβ cohesion with CD3ζ in membrane-bound or solubilised TCR-CD3. Our data provide compelling evidence that pMHC binding suffices to activate allosteric changes propagating from TCRαβ to the CD3 subunits, reconfiguring interchain transmembrane region interactions. These dynamic modifications could change the arrangement of TCR-CD3 boundary lipids to license CD3ζ phosphorylation and initiate signal propagation.Entities:
Keywords: T cell activation; T cell antigen receptor; adaptive immunity; allosteric mechanism; membrane signalling; molecular dynamics simulation
Mesh:
Substances:
Year: 2021 PMID: 34260912 PMCID: PMC8293630 DOI: 10.1016/j.celrep.2021.109375
Source DB: PubMed Journal: Cell Rep Impact factor: 9.423